About ISAAR
Past ISAARs
Photos of ISAAR
 
Past ISAARs
 
ISAAR 2007  
6th International Symposium on Antimicrobial Agents and Resistance
March 7~9, 2007
Raffles City Convention Center, Singapore
 
Keynote Lectures
Time Keynote Lectures Speakers
Keynote Lecture 1
March 7, 2007
11:00 am - 12:30 pm
History of antimicrobial therapy for the past 60
years - lessons for the future
Walter R. Wilson (Mayo Clinic, USA)
Discovery of novel antimicrobial agents Robert Moellering (Beth larael
Deaconess Medical Center, USA)
Keynote Lecture 2
March 8, 2007
4:30 pm - 5:15 pm
Antimicrobial stewardship Wing Hong Seto
(Queen Mary Hospital, Hong Kong)
Keynote Lecture 3
March 8, 2007
11:00 am - 12:30 pm
Roles of a national antibiotic reference
laboratory
David Livermore (Health Protection
Agency Centre for Infections, UK)
International network for surveillance and
strategies
Jae-Hoon Song
(Samsung Medical Center, Korea)
Keynote Lecture 4
March 8, 2007
4:30 pm - 5:15 pm
Update on HIV/AIDS Pandemic Zelalem Temesgen (Mayo Clinic, USA)
Keynote Lecture 5
March 9, 2007
11:00 am - 12:30 pm
Clinical study design in evaluating
antibacterial agents
Michael Jacobs (Case Western
Reserve Univ., USA)
 
March 7, 2007, 09:00 ~ 10:30
S1 Community-acquired pneumonia Speakers
S 1.1 Pneumococcal resistance & clinical implications Jae-Hoon Song
(Samsung Medical Center, Korea)
S 1.2 Mechanisms of pneumococcal resistance and their
clinical implications
Donald Low
(Mount Sinai Hospital, Canada)
S 1.3 Treating CAP in the era of resistance Keith Klugman (Emory Univ., USA)
S2 VRE Speakers
S 2.1 Resistance mechanisms of VRE Robin Patel (Mayo Clinic, USA)
S 2.2 Therapy of VRE Infections Robert Moellering (Beth Israel Deaconess
Medical Center, USA)
S 2.3 Controlling VRE Brenda Ang
(Tan Tock Seng Hospital, Singapore)
S3 Staphylococcal Resistance Speakers
S 3.1 CA-MRSA Li Yang Hsu (National University Hospital,
Singapore)
S 3.2 VISA/hVISA and VRSA, mechanism and clinical significance Keiichi Hiramatsu
(Juntendo Univ., Japan)
S 3.3 Treating staphylococcal infections in the era of resistance Visanu Thamlikitkul
(Siriraj Hospital, Thailand)
 
March 7, 2007, 14:30 ~ 16:00
S4 The Bug and the Lab Speakers
S 4.1 Updates and controversial issues in susceptibility
testing from the CLSI perspective
Mary Jane Ferraro (Massachusetts
General Hospital, USA)
S 1.2 Detecting of resistant bacteria fast - What’s new? Frank Cockerill (Mayo Clinic, USA)
S 1.3 Microbial typing - A weapon against resistance? Robin Patel (Mayo Clinic, USA)
S5 HIV/AIDS Speakers
S 5.1 HIV/AIDS in India and SE Asia Dilip Mathai(Christian Medical College
& Hospital, India)
S 5.2 Treating HIV/AIDS in the era of resistance Adeeba Kamarulzaman (Univ. of Malaya,
Malaysia)
S 5.3 Approach to the treatment of heavily antiretroviral
therapy - experienced HIV-infected patients
Zelalem Temesgen (Mayo Clinic, USA)
S6 Interactive session: community infections
Chair : Brenda Ang (Tan Tock Seng Hospital, Singapore)
Panels:
Walter Wilson (Mayo Clinic, USA)
Donald Low (Mount Sinai Hospital, Canada)
Dale Fisher (National Hospital, Singapore)
 
March 8, 2007, 09:00 ~ 10:30
S7 New antibiotics Speakers
S 7.1 New beta-lactam agents Karen Bush (Johnson & Johnson
Pharmaceutical R & D, USA)
S 7.2 New fluoroquinolones David Hooper (Massachusetts
General Hospital, USA)
S 7.3 Anti-parasitic agents - What's new? Nicholas White (Mahidol University,
Thailand)
S8 Fungal infections Speakers
S 8.1 Detecting antifungal resistance Frank Cockerill (Mayo Clinic, USA)
S 8.2 Molecular diagnosis of fungal infections David Denning
(Wythenshawe Hospital, UK)
S 8.3 Managing fungal infections Ban Hock Tan (Singapore General
Hospital, Singapore)
S9 Antibiotic control and regulation Speakers
S 9.1 Role of antibiotic guidelines in the control of resistance Victor Lim (International Medical
Univ., Malaysia)
S 9.2 Managing antibiotic prescribing - the nuts and bolts Keryn Christiansen (Royal Perth
Hospital, Australia)
S 9.3 Antibiotic restrictions - Are they ethical? Alastair Campbell (National University
of Singapore, Singapore)
 
March 8, 2007, 14:30 ~ 16:00
S10 PK/PD : The way to go? Speakers
S 10.1 Applying PK/PD - Will it help against resistance? John Turnidge (Women's and Children's
Hospital, Australia)
S 10.2 Are all quinolones equal with regard to resistance? David Hooper (Massachusetts General
Hospital, USA)
S 10.3 Vancomycin Dosing - Can we do Better? Robert Moellering (Beth Israel Deaconess
Medical Center, USA)
S11 Pediatric infections Speakers
S 11.1 Impact of resistance on clinical practice in pediatrics Nancy Henry (Mayo Clinic, USA)
S 11.2 The ear, nose and throat: Resistanc hideoutss Ron Dagan
(Soroka University Medical Center, Israel)
S 11.3 Pneumococcal vaccinatiosn Keith Klugman (Emory Univ., USA)
S12 Interactive session: Nosocomial infections Speakers
Chair : Ban Hock Tan (Singapore General Hospital, Singapore)
Panels:
Walter Wilson (Mayo Clinic, USA)
David Denning (Wythenshawe Hospital, UK)
Po-Ren Hsueh (National Taiwan University Hospital, Taiwan)
 
March 9, 2007, 09:00 ~ 10:30
S13 Tuberculosis Speakers
S 13.1 Detecting resistant TB fast - what's new ? Li Hwei Sng (Singapore General
Hospital, Singapore)
S 13.2 TB drug discovery Thomas Dick (Novartis Institute for
Tropical Diseases, Singapore)
S 13.3 Treatment of MDR/XDR-TB. Where we stand? Jae-Joon Yim (Seoul National Univ.,
Korea)
S14 The animals - how they affect us Speakers
S 14.1 Epidemiology and origins of antimicrobial resistance in animals Yong Ho Park (Seoul National
University, Korea)
S 14.2 The VRE story - Overview John Turnidge (Women's
and Children's Hospital, Australia)
S 14.3 Regulation of antobiotics in the food supply Paul Chiew (Agri-Food and Veterinary
Authority of Singapore, Singapore)
S15 Difficult Gram Negatives II Speakers
S 15.1 The Increasing Complexity of ESBLs Karen Bush (Johnson & Johnson
Pharmaceutical R & D, USA)
S 15.2 FQ resistance Hui Wang (Peking Union Medical
College Hospital, P.R.China)
S 15.3 Carbapenem resistance David Livermore (Health Protection
Agency Centre for Infections, UK)
 
March 9, 2007, 14:30 ~ 16:00
S16 Clinical issue: Tropical infectious diseases Speakers
S 16.1 Non-typhoid Salmonella: changing epidemiology
and resistance
Cheng Hsun Chiu (Chang Gung
Children's Hospital, Taiwan)
S 16.2 Malaria Nicholas White (Mahidol University,
Thailand)
S 16.3 Dengue control: have we made any advances? Eng Eong Ooi (Defence Science
Organisation, Singapore)
S17 Difficult Gram-negative infections (I) Speakers
S 17.1 Multiresistant or pan-resistant Acinetobacters Koh Tse Hsien (Singapore General
Hospital, Singapore)
S 17.2 Multiresistant P. aeruginosa Po-Ren Hsueh (National Taiwan Univ.
Hospital, Taiwan)
S 17.3 Multiresistant Stenotrophomonas maltophilia as a nosocomial
pathogen
Kyungwon Lee(Yonsei Univ., Korea)
S18 Nosocomial infection control Speakers
S 18.1 Novel technologies in the prevention of infection Paul Tambyah (National University
Hospital, Singapore)
S 18.2 Behavioral Change Methodologies for Implementin
Infection Control Policies
Wing Hong Seto (Queen Mary Hospital,
Hong Kong)
S 18.3 Surveillance as the key to infection control Keryn Christiansen (Royal Perth
Hospital, Singapore)
 
 
Áß¾ÓÁ¤·Ä½Ã ½ºÅ©·Ñ µû¶ó´Ù´Ï´Â ·¹À̾î
About ARFID | Sitemap | Contact us
Copyright ¨Ï ANSORP 2008. All Rights Reserved.